AXIN1 and esophageal squamous cell carcinoma: Among 81 ESCC patients, five ESCC patients had Axin gene polymorphism as well as reduced Axin protein expression, and low expression of Axin was associated with the clinicopathological characteristics of ESCC patients and was beneficial in predicting the prognosis of patients (19).